Listen: Joe Biden s already calling Kamala Harris President-Elect bizpacreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizpacreview.com Daily Mail and Mail on Sunday newspapers.
Republicans Motivated to Swing Georgia Back to Red in Senate Runoffs, Pollster Says
On 12/29/20 at 6:00 AM EST
Trafalgar Group founder Robert Cahaly told
Newsweek during an interview last week that Democrats are excited to participate following President-elect Joe Biden s win in November. In addition to denying Trump a second term in office, Biden also flipped Georgia to the Democrats for the first time since 1992.
Meanwhile, Cahaly said Republicans are concerned about the possibility of a Democrat-controlled Congress and executive branch if both Republican incumbents lose in the January 5 runoffs. In this runoff, I think you have the Democrats feeling very confident, and I think they re excited, he said. I think that will lead to significant voter participation.
The pendulum is the pits: Can the United States make enduring regulations? | American Enterprise Institute aei.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aei.org Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
What a year for the Food and Drug Administration! FDA, an agency with regulatory oversight of 20-25% of products on which consumers spend, including food and medicines, but which typically stays out of the limelight, was thrust into the public eye amidst the COVID-19 pandemic. This was the year many Americans became familiar with lesser-known and niche policies like those governing emergency use authorizations (EUAs) and with the role of FDA in regulating laboratory developed tests (LDTs). The agency also took some flak for seeming to bow to political pressure in authorizing hydroxychloroquine for emergency use as a potential COVID-19 treatment, then rescinding the authorization, as well as for its less-than-accurate pronouncements of positive data concerning convalescent plasma treatment. These were reminders that the agency Americans trust to protect the public does get things wrong sometimes and is susceptible in some w
To print this article, all you need is to be registered or login on Mondaq.com.
What a year for the Food and Drug Administration! FDA, an agency
with regulatory oversight of 20-25% of products on which consumers
spend, including food and medicines, but which typically stays out
of the limelight, was thrust into the public eye amidst the
COVID-19 pandemic. This was the year many Americans became familiar
with lesser-known and niche policies like those governing emergency
use authorizations (EUAs) and with the role of FDA in regulating
laboratory developed tests (LDTs). The agency also took some flak
for seeming to bow to political pressure in authorizing